19-14633243-A-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032571.5(ADGRE3):āc.1544T>Cā(p.Ile515Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000103 in 1,612,616 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00014 ( 0 hom., cov: 32)
Exomes š: 0.000099 ( 0 hom. )
Consequence
ADGRE3
NM_032571.5 missense
NM_032571.5 missense
Scores
2
5
11
Clinical Significance
Conservation
PhyloP100: 7.37
Genes affected
ADGRE3 (HGNC:23647): (adhesion G protein-coupled receptor E3) This gene encodes a member of the class B seven-span transmembrane (TM7) receptor family expressed predominantly by cells of the immune system. Family members are characterized by an extended extracellular region with a variable number of N-terminal epidermal growth factor (EGF)-like domains coupled to a TM7 domain via a mucin-like spacer domain. This gene is closely linked to the gene encoding egf-like molecule containing mucin-like hormone receptor 2 on chromosome 19. This protein may play a role in myeloid-myeloid interactions during immune and inflammatory responses. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.027354717).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ADGRE3 | NM_032571.5 | c.1544T>C | p.Ile515Thr | missense_variant | 12/16 | ENST00000253673.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ADGRE3 | ENST00000253673.6 | c.1544T>C | p.Ile515Thr | missense_variant | 12/16 | 1 | NM_032571.5 | P1 | |
ADGRE3 | ENST00000344373.8 | c.1388T>C | p.Ile463Thr | missense_variant | 11/15 | 1 | |||
ADGRE3 | ENST00000443157.6 | c.1166T>C | p.Ile389Thr | missense_variant | 9/13 | 2 | |||
ADGRE3 | ENST00000599900.5 | c.899T>C | p.Ile300Thr | missense_variant | 11/15 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152156Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
21
AN:
152156
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000196 AC: 49AN: 249902Hom.: 0 AF XY: 0.000178 AC XY: 24AN XY: 135090
GnomAD3 exomes
AF:
AC:
49
AN:
249902
Hom.:
AF XY:
AC XY:
24
AN XY:
135090
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000993 AC: 145AN: 1460460Hom.: 0 Cov.: 30 AF XY: 0.0000922 AC XY: 67AN XY: 726496
GnomAD4 exome
AF:
AC:
145
AN:
1460460
Hom.:
Cov.:
30
AF XY:
AC XY:
67
AN XY:
726496
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000138 AC: 21AN: 152156Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74328
GnomAD4 genome
AF:
AC:
21
AN:
152156
Hom.:
Cov.:
32
AF XY:
AC XY:
12
AN XY:
74328
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
16
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 27, 2023 | The c.1544T>C (p.I515T) alteration is located in exon 12 (coding exon 12) of the ADGRE3 gene. This alteration results from a T to C substitution at nucleotide position 1544, causing the isoleucine (I) at amino acid position 515 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;.;.;T
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationTaster
Benign
N;N;N
PrimateAI
Benign
T
PROVEAN
Pathogenic
D;D;.;D
REVEL
Benign
Sift
Uncertain
D;D;.;D
Sift4G
Pathogenic
D;D;D;D
Polyphen
D;D;.;D
Vest4
MVP
MPC
0.64
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at